WallStreetZenWallStreetZen

NASDAQ: IMMX
Immix Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their IMMX stock forecasts and price targets.

Forecast return on equity

Is IMMX forecast to generate an efficient return?

Forecast return on assets

Is IMMX forecast to generate an efficient return on assets?

IMMX revenue forecast

What is IMMX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.1M
Avg 2 year Forecast
$48.2M
Avg 3 year Forecast
$109.9M

IMMX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMMX$2.13N/AN/A
RPHM$1.69$1.43-15.21%Hold
KRON$0.96$4.25+342.71%Strong Buy
EQ$1.65$5.00+203.03%Buy
AVRO$1.20$2.00+66.67%Hold
View Top Biotech Stocks

Immix Biopharma Stock Forecast FAQ

What is IMMX's revenue growth forecast for 2026-2028?

(NASDAQ: IMMX) Immix Biopharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Immix Biopharma's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast IMMX's revenue for 2026 to be $320,452,539, with the lowest IMMX revenue forecast at $320,452,539, and the highest IMMX revenue forecast at $320,452,539. On average, 1 Wall Street analysts forecast IMMX's revenue for 2027 to be $1,271,251,587, with the lowest IMMX revenue forecast at $1,271,251,587, and the highest IMMX revenue forecast at $1,271,251,587.

In 2028, IMMX is forecast to generate $2,900,174,665 in revenue, with the lowest revenue forecast at $2,900,174,665 and the highest revenue forecast at $2,900,174,665.

If you're new to stock investing, here's how to buy Immix Biopharma stock.

What is IMMX's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: IMMX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IMMX's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: IMMX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.